Akèy › Maladi poumon entèstisyèl
Etid klinik pou Maladi poumon entèstisyèl ap rekrite nan Etazini
54 etid pou Maladi poumon entèstisyèl ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY19 etid
- Philadelphia, PA17 etid
- Los Angeles, CA15 etid
- Kansas City, KS14 etid
- Houston, TX13 etid
- Durham, NC13 etid
- Charleston, SC13 etid
- Chicago, IL13 etid
- Ann Arbor, MI11 etid
- Aurora, CO11 etid
- Boston, MA10 etid
- Birmingham, AL10 etid
- Salt Lake City, UT10 etid
- Rochester, MN10 etid
- Phoenix, AZ9 etid
- Dallas, TX9 etid
- Minneapolis, MN9 etid
- Orlando, FL9 etid
- Tampa, FL8 etid
- Cincinnati, OH8 etid
- Bend, OR7 etid
- Denver, CO7 etid
- San Francisco, CA7 etid
- Washington, DC6 etid
- Pittsburgh, PA6 etid
- Winston-Salem, NC6 etid
- Richmond, VA6 etid
- Indianapolis, IN6 etid
- Columbus, OH5 etid
- Jacksonville, FL5 etid
- Gainesville, FL5 etid
- Albuquerque, NM5 etid
- Miami, FL5 etid
- Nashville, TN5 etid
- Oklahoma City, OK5 etid
- Cleveland, OH5 etid
- Scottsdale, AZ5 etid
- New Haven, CT5 etid
- Naples, FL5 etid
- Madison, WI4 etid
Pa eta
- Alabama10 etid
- Arizona14 etid
- Colorado16 etid
- Connecticut5 etid
- Distrik Columbia5 etid
- Florid25 etid
- Georgia4 etid
- Illinois13 etid
- Indiana6 etid
- Kalifòni23 etid
- Kansas14 etid
- Kentucky4 etid
- Lwizyàn5 etid
- Maryland5 etid
- Massachusetts12 etid
- Michigan16 etid
- Minnesota15 etid
- Mississippi3 etid
- Missouri6 etid
- Nebraska3 etid
- Nevada4 etid
- New Jersey3 etid
- New Mexico5 etid
- New York21 etid
- North Carolina19 etid
- Ohio14 etid
- Oklahoma5 etid
- Oregon9 etid
- Pennsylvania19 etid
- South Carolina14 etid
- Tennessee7 etid
- Texas19 etid
- Utah10 etid
- Virginia8 etid
- West Virginia3 etid
- Wisconsin5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07201922LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT05798923Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07179380Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 23, 2026 · NCT07613099FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07540988Pulmonary Fibrosis Foundation Community Registry
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT05382572A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07323732A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06806592SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07269262A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 11, 2026 · NCT07816185A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06716606Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 8, 2026 · NCT07473700A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05878717A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06572384A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06968845A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 2, 2026 · NCT07333183Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06911632Dorothy P. and Richard P. Simmons Center for ILD Research Registry
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT00258583DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07486869Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06195072PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Ap rekriteEtid obsèvasyon
Laj 18 a 80 · Tout sèks · Mizajou Aug 18, 2026 · NCT06855329RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Ap rekriteFaz 2/3
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT06328777Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Ap rekriteFaz 2
Laj 8 a 60 · Tout sèks · Mizajou Aug 14, 2026 · NCT03630211Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.